Search images on Google Product Monograph
Active Ingredients:
- casirivimab, 1332 MG/11.1 ML
- imdevimab, 1332 MG/11.1 ML
DIN: 02516705
Dosage Form(s): SOLUTION
Route(s) of Administration: INTRAVENOUS
Description: SINGLE-USE VIALS
Schedule: COVID-19 - IO - Authorization
Company: HOFFMANN-LA ROCHE LIMITED – official site
ATC:
- J06 - IMMUNE SERA AND IMMUNOGLOBULINS (ATC, WHO, Wiki)
- J06B - IMMUNOGLOBULINS (ATC, WHO)
- J06BD - (ATC, WHO)
- J06BD07 - CASIRIVIMAB AND IMDEVIMAB (WHO)
External Links for Casirivimab And Imdevimab:
Search on Google
- Casirivimab And Imdevimab side effects
- Casirivimab And Imdevimab dosage
- casirivimab side effects
- casirivimab dosage
- imdevimab side effects
- imdevimab dosage
Hoffmann-La Roche Limited
Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find casirivimab and imdevimab photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.